Form EFFECT Clearside Biomedical,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 16, 2025 |
| Accession Number: | 0001193125-25-319171 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KSAT and Morehead State University Partner to Expand Lunar Communications Infrastructure
- 65% of New Clients Seeking Emotional and Addiction Help Had Already Turned to AI, Says Limitless Executive Solutions' Founder and Psychotherapist Nick Jonsson
- TradeLink 365 Expands Contractor Network Into New Markets Across the U.S.
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share